Company intelligence / Profile preview

UPyTher

Eindhoven, North Brabant, The Netherlandsupyther.com ↗

Ownership: Private
Development stage: Preclinical

Overview

UPyTher is developing a drug delivery platform that converts to a soft, elastic gel inside the body, increasing dwell time and exposure of active drugs in the peritoneal cavity. Their technology aims to improve therapeutic effects of existing drugs as intraperitoneal therapy[1][5].

Therapeutic areas: Oncology
Modalities: Custom drug delivery solutions
Industry: Biotech

Drug pipeline

2 assets

UPT-211

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Specipig (for development)[7]

Beyond the preview

Go deeper on UPyTher.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UPyTher.

Explore the full profile